FDA Drugs recall ·

Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg… recall

Recall number
D-0052-2027
Date
(initiated September 29, 2026)
Company / brand
Pfizer
66 Hudson Blvd, Manhattan, NY, United States
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Units affected
15,815 100-count bottles
Hazard tags
Potency
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01.

Why was it recalled?

Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot # 24W06, Exp: 11/30/2026

Distribution

US Nationwide and Puerto Rico

States: Puerto Rico

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0052-2027. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.